2 massive drugmakers are locked in a battle over the market for cancer immunotherapy — Goldman analysts say one is pulling ahead

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

Pharma giants Merck and Bristol-Myers Squibb are fighting for dominance in the multi-billion dollar cancer immunotherapy market.

 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Behind pay wall.. nice trick

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 729. in İT

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and moreDrugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants.
Fonte: MarketWatch - 🏆 3. / 97 Leggi di più »

Pharma Industry Pushes Back Against Required Listing of Drug Prices in TV AdsThe pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support. JUST MAKE IT LAW, THEY HAVE THE MONEY. What could be wrong with this? Pharma, why are you upset with telling consumers how much you are going to cost? Is it that you are worried that we will be pissed off with price gouging like the Epi-pen CEO did? Truth in advertising, what a concept!
Fonte: WSJ - 🏆 98. / 63 Leggi di più »